Development of Chimeric Antigen Receptor-Expressing iPSC-Derived Macrophages with Improved Anti-Tumor Activity

被引：3
|
作者：
Pouyanfard, Somayeh [1 ]
Fierro, Manuel [1 ]
Skaufman, Dan [1 ]
机构：
[1] Univ Calif San Diego, Div Regenerat Med, Dept Med, La Jolla, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148687
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1693
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Non-CD3-Based Chimeric Antigen Receptor (CARs) with Enhanced Anti-Tumor Activity in Solid Tumors
    Wang, Enxiu
    Wang, Liang-Chuan
    Tsai, Ching-Yi
    Bhoj, Vijay
    Albelda, Steven
    Moon, Edmund
    Milone, Michael
    MOLECULAR THERAPY, 2015, 23 : S10 - S10
  • [22] Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models
    Alberto Gabizon
    Dina Tzemach
    Jenny Gorin
    Lidia Mak
    Yasmine Amitay
    Hilary Shmeeda
    Samuel Zalipsky
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 43 - 52
  • [23] Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models
    Gabizon, Alberto
    Tzemach, Dina
    Gorin, Jenny
    Mak, Lidia
    Amitay, Yasmine
    Shmeeda, Hilary
    Zalipsky, Samuel
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 43 - 52
  • [24] Chimeric antigen receptor (CAR) T cells incorporating linker and/or transmembrane domains derived from TNFRSF19 demonstrate superior anti-tumor activity
    Xiong, Ying
    Wu, Darong
    Dropulic, Boro
    Orentas, Rimas
    Schneider, Dina
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [25] Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
    Guo, Xingliang
    Jiang, Hua
    Shi, Bizhi
    Zhou, Min
    Zhang, Honghong
    Shi, Zhimin
    Du, Guoxiu
    Luo, Hong
    Wu, Xiuqi
    Wang, Yi
    Sun, Ruixin
    Li, Zonghai
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [26] Multiplexed-engineered, iPSC-derived T cells expressing three unique targeting modalities address tumor heterogeneity and antigen escape
    Chang, Chia-Wei
    Yang, Bi-Huei
    Lin, Eason
    Shirinbak, Soheila
    Yeh, Wen-I
    Pribadi, Mochtar
    Chu, Helen
    Gutierrez, Alma
    Avramis, Earl
    ORourke, Jason
    Lee, Tom
    Witty, Alec
    Peralta, Eigen
    Hosking, Martin
    Valamehr, Bahram
    CANCER RESEARCH, 2022, 82 (12)
  • [27] Accumulation and anti-tumor effect of chimeric antigen receptor (CAR) NK cells in metastasis uveal melanoma
    Bao Quoc Lam
    Sugase, Takahito
    Terai, Mizue
    Danielson, Meggie
    Anikeyeva, Nadezhda
    Wilson, Melissa A.
    Sykulev, Yuri
    Sato, Takami
    CANCER RESEARCH, 2019, 79 (13)
  • [28] Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design
    Ghassemi, Saba
    Martinez-Becerra, Francisco J.
    Master, Alyssa M.
    Richman, Sarah A.
    Heo, David
    Leferovich, John
    Tu, Yitao
    Garcia-Canaveras, Juan Carlos
    Ayari, Asma
    Lu, Yinan
    Wang, Ai
    Rabinowitz, Joshua D.
    Milone, Michael C.
    June, Carl H.
    O'Connor, Roddy S.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 18 : 595 - 606
  • [29] iPSC-Derived NK Cells Synergize with T Cells and Anti-PD-1 Antibody to Mediate Durable Anti-Tumor Responses In Vivo
    Miller, Jeffrey S.
    Bjordahl, Ryan
    Gaidarova, Svetlana
    Mahmood, Sajid
    Rogers, Paul
    Moyar, Ge
    Blazar, Bruce R.
    Kaufman, Dan S.
    Valamehr, Bahram
    Cichocki, Frank
    BLOOD, 2019, 134
  • [30] Adoptive transfer of chimeric NKG2D receptor-expressing T cells increases survival and induces host anti-tumor immunity in a murine model of multiple myeloma
    Rynda, Agnieszka
    Barber, Amorette
    Zhang, Tong
    Sentman, Charles
    CANCER RESEARCH, 2009, 69
12345